Yield10 Bioscience Q4 EPS $(0.27) Beats $(0.30) Estimate
Portfolio Pulse from dijoy@benzinga.com
Yield10 Bioscience reported Q4 earnings with losses of $(0.27) per share, surpassing the analyst consensus estimate of $(0.30) by 10%. This represents a 59.7% improvement over the previous year's losses of $(0.67) per share.
April 01, 2024 | 8:23 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Yield10 Bioscience reported better-than-expected Q4 earnings, with losses per share of $(0.27), beating estimates by 10% and showing a 59.7% year-over-year improvement.
Yield10 Bioscience's Q4 earnings report showing a significant beat on EPS estimates and a substantial year-over-year improvement in losses is likely to be viewed positively by investors. This performance could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100